CCL2 and metabolic syndrome: Activated ECMR also increases expression of proinflammatory adipokines, including tumor necrosis factor-α (TNFα), interleukins (ILs), and monocyte chemoattractant protein-1 (MCP-1) to directly impair insulin metabolic signaling and related metabolic syndrome.